These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 27441473

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP, ORBIT-AF Investigators.
    J Am Coll Cardiol; 2015 Jun 30; 65(25):2691-8. PubMed ID: 26112191
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M, Patel K, Filippatos G, Anker SD, van Veldhuisen DJ, Cleland JG, Metra M, Aban IB, Greene SJ, Adams KF, McMurray JJ, Ahmed A.
    Eur J Heart Fail; 2013 May 30; 15(5):551-9. PubMed ID: 23355060
    [Abstract] [Full Text] [Related]

  • 28. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F, Abellana R, Verdú-Rotellar JM, Bustamante Rangel A, Clua-Espuny JL, Muñoz MA.
    Eur J Clin Invest; 2018 Nov 30; 48(11):e13014. PubMed ID: 30091171
    [Abstract] [Full Text] [Related]

  • 29. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.
    Am J Cardiol; 2008 Nov 15; 102(10):1356-60. PubMed ID: 18993155
    [Abstract] [Full Text] [Related]

  • 30. Digoxin and mortality in chronic heart failure. UK Heart Investigation.
    Lindsay SJ, Kearney MT, Prescott RJ, Fox KA, Nolan J.
    Lancet; 1999 Sep 18; 354(9183):1003. PubMed ID: 10501370
    [Abstract] [Full Text] [Related]

  • 31. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
    Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Numé AK, Gislason GH, Jhund PS, Petrie MC, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL.
    Eur J Heart Fail; 2018 Feb 18; 20(2):240-247. PubMed ID: 29148231
    [Abstract] [Full Text] [Related]

  • 32. Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
    Ruigómez A, Michel A, Martín-Pérez M, García Rodríguez LA.
    Int J Cardiol; 2016 Oct 01; 220():855-61. PubMed ID: 27400184
    [Abstract] [Full Text] [Related]

  • 33. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
    Ahmed A, Pitt B, Rahimtoola SH, Waagstein F, White M, Love TE, Braunwald E.
    Int J Cardiol; 2008 Jan 11; 123(2):138-46. PubMed ID: 17382417
    [Abstract] [Full Text] [Related]

  • 34. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP.
    J Am Heart Assoc; 2017 Jun 30; 6(7):. PubMed ID: 28666993
    [Abstract] [Full Text] [Related]

  • 35. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L, Hammar N, Rosenqvist M.
    Heart; 2010 Feb 30; 96(4):275-80. PubMed ID: 19710030
    [Abstract] [Full Text] [Related]

  • 36. Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure　- A Nationwide Cohort Study.
    Yu HT, Yang PS, Lee H, You SC, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B.
    Circ J; 2018 Feb 23; 82(3):652-658. PubMed ID: 29142156
    [Abstract] [Full Text] [Related]

  • 37. Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.
    Sessa M, Mascolo A, Andersen MP, Rosano G, Rossi F, Capuano A, Torp-Pedersen C.
    PLoS One; 2016 Feb 23; 11(7):e0160337. PubMed ID: 27467520
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Abdul-Rahim AH, MacIsaac RL, Jhund PS, Petrie MC, Lees KR, McMurray JJ, On behalf the VICCTA-Heart Failure Collaborators.
    Int J Cardiol; 2016 Apr 15; 209():310-6. PubMed ID: 26913372
    [Abstract] [Full Text] [Related]

  • 39. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF, Gheorghiade M.
    Circulation; 2006 Aug 01; 114(5):397-403. PubMed ID: 16864724
    [Abstract] [Full Text] [Related]

  • 40. Digoxin in advanced heart failure patients: a question of rhythm.
    Jorge E, Baptista R, Martins H, Saraiva F, Costa S, Vieira H, Coelho L, Monteiro P, Franco F, Providência LA.
    Rev Port Cardiol; 2013 Apr 01; 32(4):303-10. PubMed ID: 23528436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.